Ambu A/S Class B

Ambu A/S Class B

12.05
EUR
-0.07
(-0.58%)
0.32EPS
28.25P/E
2.39BMarket Cap
Jan 28Next Earn
Ambu A/S Class B
STU:547A
(Stuttgart Stock Exchange)

Recent

price

12.05

P/E

ratio

28.25

div

yld

0.46%

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
DKK
4.21
4.48
5.91
6.68
7.86
8.79
9.94
10.72
11.54
14.47
15.94
17.5
18.33
20.24
- -
24.45
24.46
Revenue per Share
0.3
0.47
0.2
0.64
0.63
1.05
1.27
1.39
1.3
0.98
0.98
0.37
0.64
0.88
- -
2.43
2.43
Basic EPS, GAAP
0.25
0.55
0.52
0.73
0.87
1.31
1.95
1.31
1.11
-0.55
-1.02
-1.8
0.74
1.97
- -
1.84
1.84
Free Cash Flow per Basic Share
0.12
0.1
0.15
0.06
0.19
0.19
0.32
0.38
0.41
0.39
0.29
0.3
- -
- -
- -
0.42
0.42
Dividend per Share
2.91
2.83
2.77
3.59
4.31
4.21
5.39
7.73
8.89
9.57
15.58
16.77
20.25
21
- -
23.98
23.98
Book Value per Share
1.8
1.86
-1.16
-0.62
-0.21
-1.06
0.27
-3.11
-2.47
-2.27
2.79
2.53
6.69
8.87
- -
9.75
9.75
Tangible Book Value per Share
234
233
234
237
240
237
237
243
244
247
252
254
260
266
266
265
265
Basic Weighted Avg Shares
983
1,045
1,383
1,584
1,889
2,084
2,355
2,606
2,820
3,567
4,013
4,444
4,775
5,391
- -
6,471
6,471
Sales/Revenue/Turnover
14.68
14.45
11.42
12.5
12.76
17.08
19.53
21.6
17.02
12
8.47
2.75
6.32
11.96
- -
13.15
13.15
Operating Margin (%)
56
53
74
88
96
102
105
115
109
181
216
351
348
696
370
401
401
Depreciation Expense
69
110
48
151
152
250
301
337
317
241
247
93
168
235
- -
642
642
Net Income, GAAP
29.42
23.61
31.43
27.4
29.3
23.31
23.41
27.53
23.24
25.16
19.81
14.68
20
21.67
- -
23.57
23.57
Effective Tax Rate (%)
7.04
10.53
3.47
9.53
8.05
12
12.78
12.93
11.24
6.76
6.15
2.09
3.52
4.36
- -
9.92
9.92
Profit Margin (%)
231
297
298
351
400
381
-284
511
154
197
628
1,143
1,066
1,578
- -
1,778
1,778
Working Capital
30
18
753
702
700
925
83
1,304
1,151
1,401
760
1,766
512
483
- -
502
502
LT Debt
580
665
651
854
1,036
990
1,279
1,882
2,182
2,372
3,952
4,261
5,393
5,594
- -
6,251
6,251
Total Equity
11.1
14.78
6.16
9.07
9.27
13.94
16.76
15.29
7.05
8.91
6.37
1.91
4.01
8.32
- -
- -
- -
Return on Invested Capital (%)
11.34
15.52
5.65
11.5
9.87
14.39
16.13
13.68
10.18
7.32
6.24
2.21
3.59
4.22
- -
- -
- -
Return on Capital (%)
12.13
17.67
7.29
20.07
16.08
24.68
26.53
21.32
15.6
10.58
7.81
2.26
3.48
4.28
- -
- -
- -
Return on Common Equity (%)

Capital Structure

DKK

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
85
87
91
LT Borrowings
17
19
33
LT Finance Leases
449
473
469
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
266
263
261
Market Capitalization
18,424
16,060
17,869

Working Capital

DKK

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
3,013
3,069
3,095
Cash, Cash Equivalents & STI
691
705
536
Accounts Receivable, Net
907
970
1,017
Inventories
1,231
1,202
1,360
Total Current Liabilities
1,032
1,108
1,317
Payables & Accruals
- -
- -
- -
ST Debt
85
87
91
Deferred Revenue
- -
- -
- -

Growth Rates

DKK

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
- -
Free Cash Flow
- -
- -
- -
Net Income, GAAP
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

DKK

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,254
1,367
1,383
1,387
5,391
2025
1,510
1,554
1,507
- -
- -
2026
1,558
1,573
1,640
1,700
6,471

Quarterly Earnings Per Share

DKK

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.35
0.54
0.5
-0.51
0.88
2025
0.68
0.71
0.46
- -
- -
2026
0.44
0.46
0.59
0.94
2.43

Quarterly Dividends Per Share

DKK

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
0.3
0.08
- -
- -
- -
2026
0.34
0.08
- -
- -
0.42
Business
Ambu A/S (Ticker: AMBU-B.CO) develops, manufactures, and markets single-use flexible endoscopic devices and related visualization systems for medical diagnostics and treatment procedures. The company offers a comprehensive portfolio of products including flexible endoscopes such as the aScope line of bronchoscopes, duodenoscopes, cystoscopes, and ureteroscopes; disposable sheaths and cleaning brushes; and advanced imaging solutions like the aView and aBox systems for video processing and display. Ambu also provides rigid endoscopy products, patient monitoring devices, and resuscitators, serving healthcare providers in hospitals, clinics, and ambulatory settings worldwide. Founded in 1937 and headquartered in Ballerup, Denmark, Ambu operates globally with manufacturing facilities in Europe, North America, and Asia, targeting key markets in endoscopy, anesthesia, and cardiology segments. Its core customer base includes physicians, nurses, and medical facilities focused on minimally invasive procedures, with a strong emphasis on infection prevention through single-use devices. The company maintains subsidiaries in major regions, including Ambu Inc. in the United States, supporting its international expansion. In the last 1-2 years, Ambu has launched several new products, including the aScope™ 5 Slim Broncho and advancements in its aScope™ Gastro platform for gastrointestinal endoscopy, enhancing procedural efficiency and safety. The company completed strategic acquisitions such as the 2024 purchase of a key visualization technology firm to bolster its digital endoscopy offerings and formed partnerships with leading hospital networks for pilot programs in single-use endoscopy adoption. Additionally, Ambu announced expansions in its U.S. manufacturing capacity in 2025 to meet growing demand in North American markets amid regulatory shifts favoring disposable devices.

Company News

  • NovoCure (NASDAQ:NVCR) and Ambu A/S (OTCMKTS:AMBBY) Head to Head Contrast

  • Reviewing ICU Medical (NASDAQ:ICUI) & Ambu A/S (OTCMKTS:AMBBY)

  • Ambu A/S (AMBBY) Q3 2026 Earnings Call Transcript

  • Ambu A/S (OTCMKTS:AMBBY) Sees Large Volume Increase – What’s Next?

  • Ambu A/S (AMBBY) Q1 2026 Earnings Call Transcript

  • Ambu A/S (AMBBY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

  • Ambu A/S (OTCMKTS:AMBBY) Trading 3.4% Higher – Still a Buy?

  • Ambu A/S (AMBBY) Shareholder/Analyst Call Prepared Remarks Transcript

  • Ambu A/S (AMBBY) Q4 2025 Earnings Call Transcript

  • Ambu upgraded to Buy from Hold at Nordea

  • Ambu A/S (AMBFF) Q4 2024 Earnings Call Transcript

  • Ambu A/S (AMBFF) Q1 2024 Earnings Call Transcript

  • Ambu A/S (AMBFF) Q2 2023 Earnings Call Transcript

  • Ambu A/S (AMBFF) Q4 2022 Earnings Call Transcript